Time From HIV Diagnosis to Viral Suppression: Survival Analysis of Statewide Surveillance Data in Alabama, 2012 to 2014

Author:

Batey D ScottORCID,Dong XueyuanORCID,Rogers Richard P,Merriweather AnthonyORCID,Elopre LateshaORCID,Rana Aadia IORCID,Hall H IreneORCID,Mugavero Michael JORCID

Abstract

Background Evaluation of the time from HIV diagnosis to viral suppression (VS) captures the collective effectiveness of HIV prevention and treatment activities in a given locale and provides a more global estimate of how effectively the larger HIV care system is working in a given geographic area or jurisdiction. Objective This study aimed to evaluate temporal and geographic variability in VS among persons with newly diagnosed HIV infection in Alabama between 2012 and 2014. Methods With data from the National HIV Surveillance System, we evaluated median time from HIV diagnosis to VS (<200 c/mL) overall and stratified by Alabama public health area (PHA) among persons with HIV diagnosed during 2012 to 2014 using the Kaplan-Meier approach. Results Among 1979 newly diagnosed persons, 1181 (59.67%) achieved VS within 12 months of diagnosis; 52.6% (353/671) in 2012, 59.5% (377/634) in 2013, and 66.9% (451/674) in 2014. Median time from HIV diagnosis to VS was 8 months: 10 months in 2012, 8 months in 2013, and 6 months in 2014. Across 11 PHAs in Alabama, 12-month VS ranged from 45.8% (130/284) to 84% (26/31), and median time from diagnosis to VS ranged from 5 to 13 months. Conclusions Temporal improvement in persons achieving VS following HIV diagnosis statewide in Alabama is encouraging. However, considerable geographic variability warrants further evaluation to inform public health action. Time from HIV diagnosis to VS represents a meaningful indicator that can be incorporated into public health surveillance and programming.

Publisher

JMIR Publications Inc.

Subject

Public Health, Environmental and Occupational Health,Health Informatics

Reference32 articles.

1. Centers for Disease Control and Prevention201707272017-11-16HIV Continuum of Care, US, 2014, Overall and by Age, Race/Ethnicity, Transmission Route and Sexhttps://www.cdc.gov/nchhstp/newsroom/2017/HIV-Continuum-of-Care.html

2. HIV.gov20152020-02-27National HIV/AIDS Strategy for the United States: Updated to 2020https://www.hiv.gov/federal-response/national-hiv-aids-strategy/nhas-update

3. UNAIDSThe Joint United Nations Programme on HIV/AIDS (UNAIDS)20142020-03-0390-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemichttps://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf

4. HIV Care Visits and Time to Viral Suppression, 19 U.S. Jurisdictions, and Implications for Treatment, Prevention and the National HIV/AIDS Strategy

5. Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3